Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial
Authors:
- Michelle S. TrocheMTMichelle S. Troche
- James A. CurtisJCJames A. Curtis
- Jordanna S. SevitzJSJordanna S. Sevitz
- Avery E. DakinADAvery E. Dakin
- Sarah E. PerrySPSarah E. Perry
- James C. BordersJBJames C. Borders
- Alessandro A. GrandeAGAlessandro A. Grande
- Yuhan MouYMYuhan Mou
- Nora Vanegas‐ArroyaveNVNora Vanegas‐Arroyave
- Karen W. HeglandKHKaren W. Hegland
- 7 November 2022
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 38 (2) , 201-211
Abstract
Background: Disorders of airway protection (cough and swallowing) are pervasive in Parkinson's disease (PD) resulting in a high incidence of aspiration pneumonia and death. However, there are no randomized controlled trials comparing strength and skill‐based approaches to improve airway protection in PD.Objectives: The aim of this study was to compare expiratory muscle strength training (EMST) and sensorimotor training for airway protection (smTAP) to improve cough‐related outcomes in people with PD.Methods: Participants with PD and dysphagia were recruited for this prospective phase II randomized‐blinded controlled clinical trial. Participants completed baseline assessment, 5 weeks of EMST or smTAP, and a post‐training assessment. Primary outcome measures included maximum expiratory pressure (MEP) and voluntary cough peak expiratory flow rate (PEFR). Mixed effects models were used to assess the effects of EMST and smTAP on outcomes.Results: A total of 65 participants received either EMST (n = 34) or smTAP (n = 31). MEP improved from pre‐ to post‐treatment for smTAP (P < 0.001, d = 0.19) and EMST (P < 0.001, d = 0.53). Voluntary PEFR increased from pre‐ to post‐treatment for smTAP (P < 0.001, d = 0.19) and EMST (P < 0.001, d = 0.06). Moreover, reflex cough PEFR (P < 0.001, d = 0.64), reflex cough expired volume (P < 0.001, d = 0.74), and urge to cough (P = 0.018, OR = 2.70) improved for the smTAP group but not for the EMST group.Conclusions: This clinical trial confirmed the efficacy of smTAP to improve reflex and voluntary cough function, above and beyond EMST, the current gold standard. © 2022 International Parkinson and Movement Disorder Society.Keywords
This publication has 43 references indexed in Scilit:
- Volitional control of reflex coughJournal of Applied Physiology, 2012
- Aspiration and swallowing in Parkinson disease and rehabilitation with EMSTNeurology, 2010
- The cause of death in idiopathic Parkinson’s diseaseParkinsonism & Related Disorders, 2010
- Voluntary Cough Production and Swallow Dysfunction in Parkinson’s DiseaseDysphagia, 2008
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 yearsMovement Disorders, 2008
- Silent aspiration in Parkinson's disease patients with diurnal sialorrheaClinical Neurology and Neurosurgery, 2008
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Effects of Respiratory Muscle Weakness on Daily Living Function, Quality of Life, Activity Levels, and Exercise Capacity in Mild to Moderate Parkinsonʼs DiseaseAmerican Journal of Physical Medicine & Rehabilitation, 2004
- Survival time, mortality, and cause of death in elderly patients with Parkinson's disease. A 9‐year follow‐upMovement Disorders, 2003